Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long Acting Subcutaneous Compared to Short Acting Sublingual Buprenorphine Administration in Pregnant and Lactating Women

NCT04212065 is registered in ClinicalTrials.gov with Ohio State University as lead sponsor.

NCT NCT04212065
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04212065 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long Acting Subcutaneous Compared to Short Acting Sublingual Buprenorphine Administration in Pregnant and Lactating Women
Lead sponsor
Ohio State University
Phase
Phase 4
Overall status
Withdrawn
Start date
February 21, 2020
Completion date
September 1, 2020
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

opioid use disorder